DJIA 16,472.37 200.36 1.23%
NASDAQ 4,707.78 80.69 1.74%
S&P 500 1,951.36 27.54 1.43%
market minute promo

GlaxoSmithKline (NYSE: GSK)

39.50 0.76 (1.96%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

GSK $39.50 1.96%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $38.61
Previous Close $38.74
Daily Range $38.38 - $39.50
52-Week Range $37.24 - $49.08
Market Cap $85.8B
P/E Ratio 13.31
Dividend (Yield) $2.31 (6.4%)
Ex-Dividend Date
Dividend Pay Date
Volume 3,391,002
Average Daily Volume 3,705,262
Current FY EPS $2.39




Drug Makers

GlaxoSmithKline (GSK) Description

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products. Website:

News & Commentary

Clinton Proposals Could Spell Trouble for These 3 Drugmakers

An empowered Medicare program could pressure sales for GlaxoSmithKline, Merck, and Celgene.

Mirna Therapeutics: A Healthy IPO To Start The Week

3 Stocks We're Ready to Sell

When the market gets choppy, it can be a good time take a hard look at your portfolio.

Glaxo's Eosinophilic Asthma Drug Nucala Wins CHMP Backing

GlaxoSmithKline (GSK) Stock: Is the Worst Over?

3 Drugs Stocks Pushing Industry Growth

Buy-Rated Dividend Stocks In The Top 3: GSK, WY, LVS

Eli Lilly (LLY) Stock, Full of Life With a 30% Upside

Introduction To Dr De's Real-Time Biotech Stock Trade Alert Service

Heat Biologics' Cancer Vaccines May Boost Efficacy Of Checkpoint Inhibitors

See More GSK News...

GSK's Top Competitors

GSK $39.50 (1.96%)
Current stock: GSK
JNJ $93.93 (0.82%)
Current stock: JNJ
NVS $93.27 (1.49%)
Current stock: NVS
RHHBY $33.32 (0.32%)
Current stock: RHHBY